COVID-19 vaccine mock drill in 21 Chhattisgarh districts on January 7, 8

Last week, a similar mock drill was held in Chhattisgarh's capital Raipur and six other districts out of the total 28 districts in the State.

January 06, 2021 12:05 pm | Updated 12:06 pm IST - Raipur

Image used for representational purpose.

Image used for representational purpose.

A dry run to assess the readiness for the COVID-19 vaccination drive will be held in 21 districts of Chhattisgarh over the next two days, a senior state health official said on Wednesday.

Last week, a similar mock drill was held in Chhattisgarh's capital Raipur and six other districts out of the total 28 districts in the State.

Now, it will be held in the remaining 21 districts for the assessment of preparation for the imminent coronavirus vaccination drive, mission director for National Health Mission in Chhattisgarh, Priyanka Shukla, told PTI .

The dry run will be conducted in Balrampur, Bijapur, Dantewada, Jashpur, Kanker, Kondagaon, Korea, Narayanpur, Sukma and Surajpur districts on Thursday, and in Balod, Raigarh, Balodabazar, Bemetara, Dhamtari, Gariaband, Janjgir- Champa, Kawardha, Korba, Mahasamund and Mungeli on Friday, the official said.

The chief medical and health officers (CMHOs) of these districts have been directed to make necessary arrangements for the drill that will be held in one urban and one rural centre of each district from 10.00a.m. to 2.00p.m., she said.

After 5.00p.m., the district task force concerned will review the entire process and submit its report by January 9, the official said.

All necessary preparations like the selection of place, sending and receiving of mock vaccines, preparation of session in the Co-WIN app, and appointment of invigilator at the centre will be completed before the drill, she added.

Prior to the dry run, a state-level monitoring team will inspect the vaccination centres, she added.

Chhattisgarh's COVID-19 caseload reached 2,84,536 on Tuesday. Of these, 2,71,988 people have so far recovered, while 3,437 patients have till now died due to the disease, as per official figures.

The Drugs Controller General of India on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive.

Top News Today

Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.